Digitisation | August 05, 2021
Clarivate acquires Bioinfogate
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Natco has withdrawn its application filed with the Indian Patent Office, seeking Compulsory License against Lilly for Baricitinib for Covid-19 in India
The agreement will help ensure wider reach and access to patients in India
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
DST-backed researchers from Pune demonstrate targeted gene-silencing approach that significantly inhibits tumor growth with minimal toxicity
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
Subscribe To Our Newsletter & Stay Updated
